Trusting the dynamism in nature and the capacity evolved in nature over billions of years, we believe that understanding how nature controls bacterial communities is essential to harness the same power to control bacterial pathogens in infection situations. Our lab is focused on two areas of research into developing alternative therapies against human bacterial pathogens. We are interested in developing , 1. Phage based therapies, small viruses that specifically infect bacteria and which do not have the capacity to infect humans, 2. Using other harmless bacteria to control pathogenic bacteria. We have been progressing in developing phage-pathogen systems and phage based tools; and bacterially produced antimicrobials against pathogenic bacteria for a number of pathogens such as C. difficile, P. aeruginosa, P. acnes, G. vaginalis, A. baumannii. Characterization studies on genomics, single or multiple infection assays in culture and in animal rescue models, provided valuable basic information for their therapeutic efficacy alone or in combination with antibiotics.